Neonatal lupus erythematosus complicated by mucocutaneous and visceral hemangiomas
Authors:
- 1 November 2007
- journal article
- case report
- Published by SAGE Publications in Lupus
- Vol. 16 (11) , 904-907
Abstract
Neonatal lupus erythematosus (NLE) is a passively acquired autoimmune syndrome resulting from transplacental passage of maternal anti-Ro/SSA and/or anti-La/SSB antibodies to the fetus. Characteristic manifestations of NLE include transient dermatitis, hepatic and hematologic abnormalities and congenital heart block. Skin lesions in NLE resemble subacute cutaneous lupus erythematosus and typically consist of annular, erythematous, scaly plaques. Telangiectasias, vascular abnormalities resulting from dilation of superficial dermal vessels, may also affect the skin in a minority of patients. The etiology of telangiectasias in NLE is unknown, but disordered angiogenesis likely plays a role. Hemangiomas are a common disorder of angiogenesis frequently encountered in infancy. There have been no reported cases of neonatal lupus associated with the development of hemangiomas. We present a case of an infant diagnosed with NLE after manifesting classic dermatitis, hepatic and hematologic abnormalities who later developed mucocutaneous and visceral hemangiomas. We further postulate that disordered angiogenesis, possibly dysregulated production of vascular endothelial growth factor, may play a primary role in the development of these cutaneous vascular lesions in NLE. Lupus (2007) 16, 904—907.Keywords
This publication has 9 references indexed in Scilit:
- Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosusPediatric Allergy and Immunology, 2007
- A case of systemic lupus erythematosus with giant hepatic cavernous hemangiomaLupus, 2004
- Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-Ro autoantibodiesThe Journal of Pediatrics, 2003
- Hemangiomas of infancyJournal of the American Academy of Dermatology, 2003
- Vascular endothelial growth factor and its soluble receptors VEGFR‐1 and VEGFR‐2 in the serum of patients with systemic lupus erythematosusMediators of Inflammation, 2003
- Cutaneous manifestations of neonatal lupus without heart block: Characteristics of mothers and children enrolled in a national registryThe Journal of Pediatrics, 2000
- The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosusJournal of the American Academy of Dermatology, 1999
- Proliferative Hemangiomas: Analysis of Cytokine Gene Expression and AngiogenesisPlastic and Reconstructive Surgery, 1999
- Cutaneous telangiectases in neonatal lupus erythematosusJournal of the American Academy of Dermatology, 1995